Saturday 17 October 2026 Export EIGRQ’s income statement to Excel — free account

Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $15.8 million, up 17.0% from fiscal 2022. Revenue growth for three consecutive years, operating cash flow growth for three.

8.50 0.00 0.00%

Follow EIGRQ

Alert me

Market cap: $2.6M
P/E: 0.0×
Fwd P/E: −0.8×
Dividend yield: —
F-score: 4/9
Altman Z: −24.53
Beneish M: −3.24
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Dec '23	Sep '23	Jun '23	Mar '23	Older periods
Piotroski F-Score Full definition →	4	—	—	—	+8 more TTM periods Free account
ROE Full definition →	(367.00%)	(225.93%)	(161.95%)	(146.28%)
ROA Full definition →	(94.31%)	(86.91%)	(81.11%)	(76.75%)
ROIC Full definition →	(3,674.55%)	0.00%	(2,469.33%)	(14,894.98%)
Return on Tangible Assets Full definition →	505.89%	(223.45%)	(175.56%)	(131.47%)
Average Days of Receivables Full definition →	38.92	32.88	87.59	95.13
Free Cash Flow per Share Full definition →	(50.67)	(56.44)	(60.61)	(60.62)
Free Cash Flow Full definition →	(74.78)	(83.30)	(89.41)	(89.11)
Capital Expenditures Full definition →	(0.23)	(0.46)	(0.56)	(0.56)
Other line items
Cash ROIC Full definition →	(143.53%)	(105.77%)	(81.60%)	(59.04%)
Accounts Receivable Turnover Full definition →	9.19	7.76	6.51	4.83
Accounts Payable Turnover Full definition →	0.00	0.03	0.19	0.18
Inventory Turnover Full definition →	0.01	0.14	0.70	0.51
Average Days of Payables Full definition →	32,165.63	6,616.31	1,304.40	2,345.89
Days of Inventory on Hand Full definition →	23,664.17	1,504.94	289.57	1,056.03
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	395.18%	472.10%	496.53%	498.76%
Selling, General and Administrative Expense of Revenue Full definition →	159.79%	196.39%	195.81%	213.06%
Share Based Compensation of Revenue Full definition →	31.75%	42.04%	47.47%	59.03%
Interest Coverage Full definition →	(13.13)	(7.95)	(9.42)	(10.28)
Operating CF/Net income Full definition →	0.99	0.96	0.93	0.91
Depreciation/Fixed assets Full definition →	(1.33)	(1.14)	(0.50)	0.34
Capex/Depreciation Full definition →	0.28	0.59	1.51	(2.05)
Revenue per Share Full definition →	10.69	9.94	10.49	10.16
Operating CF per Share Full definition →	(50.51)	(56.13)	(60.23)	(60.24)
Capex per Share Full definition →	(0.16)	(0.31)	(0.38)	(0.38)
Capex to Sales Full definition →	0.01	0.03	0.04	0.04

Show all line items

Columns are period end dates

Stockrow Weekly